Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001011438-25-000504·Indivior Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
INDIVIOR PLC
Ordinary Shares, $0.50 nominal value per share · CUSIP: G4766E116
Event date: 2025-11-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Two Seas Capital LPReported CIK 0001823138
Shares: 9,254,152 · Class: 7.4%
- Two Seas Capital GP LLC
Shares: 9,254,152 · Class: 7.4%
- Sina Toussi
Shares: 9,254,152 · Class: 7.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001011438-25-000504
- Form type
- SCHEDULE 13D/A
- Filer
- Indivior Pharmaceuticals, Inc.
- CIK
- CIK 1625297
- Filed
- Nov 05, 2025
- Reporting period
- Nov 03, 2025
- Description
- Schedule 13D beneficial ownership